These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 11956598

  • 1. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
    Forslund A, Engarås B, Lönnroth C, Lundholm K.
    Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
    [Abstract] [Full Text] [Related]

  • 2. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.
    Anticancer Res; 2000 May; 20(6D):5195-8. PubMed ID: 11326694
    [Abstract] [Full Text] [Related]

  • 3. Preoperative serum levels of CEA and CA 19-9 and their prognostic significance in colorectal carcinoma.
    Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Pahl H, Fateh-Moghadam A.
    Anticancer Res; 1997 May; 17(4B):2935-8. PubMed ID: 9329568
    [Abstract] [Full Text] [Related]

  • 4. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
    Engarås B, Kewenter J, Nilsson O, Wedel H, Hafström L.
    Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of predictive biomarkers for therapeutical strategies in colorectal cancer.
    Gasser M, Gerstlauer C, Grimm M, Bueter M, Lebedeva T, Lutz J, Maeder U, Ribas C, Ribas C, Nichiporuk E, Thalheimer A, Heemann U, Thiede A, Meyer D, Waaga-Gasser AM.
    Ann Surg Oncol; 2007 Apr; 14(4):1272-84. PubMed ID: 17211733
    [Abstract] [Full Text] [Related]

  • 6. [Prognostic study of preoperative serum levels of CEA and CA 19-9 in colorectal cancer].
    Uehara M, Manaka D, Baba S, Oji Y, Hirata K, Shimizu M, Noguchi M.
    Gan To Kagaku Ryoho; 2007 Sep; 34(9):1413-7. PubMed ID: 17876139
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma.
    Diez M, Cerdán FJ, Pollán M, Maestro ML, Ortega MD, Martínez S, Moreno G, Balibrea JL.
    Anticancer Res; 1994 Sep; 14(6B):2819-25. PubMed ID: 7872725
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
    Reiter W, Stieber P, Reuter C, Nagel D, Cramer C, Pahl H, Fateh-Moghadam A.
    Anticancer Res; 1997 Sep; 17(4B):2903-6. PubMed ID: 9329559
    [Abstract] [Full Text] [Related]

  • 9. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
    Park IJ, Choi GS, Lim KH, Kang BM, Jun SH.
    Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
    [Abstract] [Full Text] [Related]

  • 10. Can preoperative and postoperative CEA predict survival after colon cancer resection?
    Slentz K, Senagore A, Hibbert J, Mazier WP, Talbott TM.
    Am Surg; 1994 Jul; 60(7):528-31; discussion 531-2. PubMed ID: 8010568
    [Abstract] [Full Text] [Related]

  • 11. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D, Nürnberg R, Bahlo M, Klapdor R.
    Anticancer Res; 1999 Jul; 19(4A):2443-50. PubMed ID: 10470173
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A, Caciagli M, Zampieri F, Ciampalini G, Carpi A, Spisni R, Colizzi C.
    Cancer Detect Prev; 1995 Jul; 19(2):183-95. PubMed ID: 7750106
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of pre- and postoperative serum carcinoembryonic antigen levels in patients with colorectal cancer.
    Wang JY, Lu CY, Chu KS, Ma CJ, Wu DC, Tsai HL, Yu FJ, Hsieh JS.
    Eur Surg Res; 2007 Jul; 39(4):245-50. PubMed ID: 17457032
    [Abstract] [Full Text] [Related]

  • 14. Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
    Kos J, Nielsen HJ, Krasovec M, Christensen IJ, Cimerman N, Stephens RW, Brünner N.
    Clin Cancer Res; 1998 Jun; 4(6):1511-6. PubMed ID: 9626470
    [Abstract] [Full Text] [Related]

  • 15. Factors predictive of survival in patients with node-positive colorectal cancer in Taiwan.
    Wang WS, Chen PM, Chiou TJ, Liu JH, Fan FS, Lin TC, Jiang JK, Yang SH, Yen CC, Wang HS, Lin JK.
    Hepatogastroenterology; 2000 Jun; 47(36):1590-4. PubMed ID: 11149009
    [Abstract] [Full Text] [Related]

  • 16. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
    Spila A, Ferroni P, Cosimelli M, D'Alessandro R, Abbolito MR, Mariotti S, Aloe S, Carone MD, Graziano F, Tedesco M, Martini F, Mancini R, Stigliano V, Roselli M, Guadagni F.
    Anticancer Res; 2001 Jun; 21(2B):1263-70. PubMed ID: 11396197
    [Abstract] [Full Text] [Related]

  • 17. [Serum anti-p53 antibodies and CEA in monitoring of recurrences of colorectal cancer].
    Bielicki D, Sulzyc-Bielicka V, Domagała W.
    Ann Acad Med Stetin; 2008 Jun; 54(3):99-104. PubMed ID: 19839520
    [Abstract] [Full Text] [Related]

  • 18. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of preoperative carcinoembryonic antigen level in colorectal cancer in Tunisia.
    Gara S, Meziou S, Mtar A, Ghanem A, Harzallah L, Rahal K, Boussen H, Guemira F.
    Tunis Med; 2012 Jan; 90(1):41-4. PubMed ID: 22311447
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N.
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.